Q3 FY2026
Filed Nov 5, 2026F&G reports record AUM before reinsurance of $76.2 billion and GAAP net earnings of $736 million, while adjusted net earnings fell to $96 million ($0.74 per share) from $165 million ($1.22 per share).
GAAP results rose sharply, with net earnings to common shareholders of $736 million against $114 million, but the company attributes the increase mainly to $652 million of favorable market related liability adjustments, including a $297 million actuarial reserve release. Adjusted net earnings fell 42% year over year, alternative investment income of $60 million was below the approximately 12% long-term expected return, and gross and net sales declined from the prior year quarter. Record AUM before reinsurance and record core retail sales support the growth side of the read.
Key metrics
shortened, hover for the filing’s print| Metric | Value | q/q | y/y |
|---|---|---|---|
| AUM before reinsurance, Q3 2026 (period end)non-GAAP | $76.23B | – | 7% |
| Assets under management (AUM, retained), Q3 2026 (period end)non-GAAP | $56.21B | – | – |
| Gross sales, Q3 2026non-GAAP | $3B | – | – |
| Net sales, Q3 2026non-GAAP | $1.41B | – | – |
| Core sales, Q3 2026non-GAAP | $2.36B | – | – |
| Indexed annuities (FIA/RILA) sales, Q3 2026non-GAAP | $2.14B | – | – |
| Pension risk transfer (PRT) sales, Q3 2026non-GAAP | $172M | – | – |
| Opportunistic sales, Q3 2026non-GAAP | $643M | – | – |
| Total revenues, Q3 2026GAAP | $1.13B | – | – |
| Life insurance premiums and other fees, Q3 2026GAAP | $330M | – | – |
| Interest and investment income, Q3 2026GAAP | $698M | – | – |
| Owned distribution revenues, Q3 2026GAAP | $20M | – | – |
| Recognized gains and (losses), net, Q3 2026GAAP | $83M | – | – |
| Benefits and other changes in policy reserves, Q3 2026GAAP | $26M | – | – |
| Market risk benefit losses (gains), Q3 2026GAAP | −$167M | – | – |
| Depreciation and amortization, Q3 2026GAAP | $191M | – | – |
| Personnel costs, Q3 2026GAAP | $73M | – | – |
| Other operating expenses, Q3 2026GAAP | $30M | – | – |
| Interest expense, Q3 2026GAAP | $42M | – | – |
| Total benefits and expenses, Q3 2026GAAP | $195M | – | – |
| Earnings before income taxes, Q3 2026GAAP | $936M | – | – |
| Income tax expense (benefit), Q3 2026GAAP | $195M | – | – |
| Net earnings (loss), Q3 2026GAAP | $741M | – | – |
| Net earnings (loss) attributable to common shareholders, Q3 2026GAAP | $736M | – | – |
| Net earnings per diluted share, Q3 2026GAAP | $5.48 | – | – |
| Adjusted net earnings attributable to common shareholders, Q3 2026non-GAAP | $96M | – | – |
| Adjusted net earnings per diluted share, Q3 2026non-GAAP | $0.74 | – | – |
| Adjusted return on average equity, excluding AOCI, Q3 2026 (rolling four quarters)non-GAAP | 6.7% | – | – |
| Adjusted return on assets, Q3 2026 (year-to-date annualized)non-GAAP | 0.69% | – | – |
| Book value per common share, Q3 2026 (period end)GAAP | $31.48 | – | – |
| Book value per common share excluding AOCI, Q3 2026 (period end)non-GAAP | $51.37 | $5.44 per share increase | – |
| Total F&G equity attributable to common shareholders, excluding AOCI, Q3 2026 (period end)non-GAAP | $6.73B | $712 million increase | – |
| Total revenues, nine months 2026GAAP | $3.74B | – | – |
| Life insurance premiums and other fees, nine months 2026GAAP | $1.20B | – | – |
| Interest and investment income, nine months 2026GAAP | $2.14B | – | – |
| Recognized gains and (losses), net, nine months 2026GAAP | $341M | – | – |
| Earnings before income taxes, nine months 2026GAAP | $1.17B | – | – |
| Income tax expense (benefit), nine months 2026GAAP | $250M | – | – |
| Net earnings (loss), nine months 2026GAAP | $915M | – | – |
| Net earnings (loss) attributable to common shareholders, nine months 2026GAAP | $899M | – | – |
| Net earnings per diluted share, nine months 2026GAAP | $6.66 | – | – |
| Adjusted net earnings attributable to common shareholders, nine months 2026non-GAAP | $291M | – | – |
| Adjusted net earnings per diluted share, nine months 2026non-GAAP | $2.20 | – | – |
| Gross sales, nine months 2026non-GAAP | $8.89B | – | – |
| Net sales, nine months 2026non-GAAP | $5.11B | – | – |
| Core sales, nine months 2026non-GAAP | $6.32B | – | – |
| Adjusted return on average equity, excluding AOCI, nine months 2026non-GAAP | 6.7% | – | – |
| Adjusted return on assets, nine months 2026non-GAAP | 0.69% | – | – |
Capital returns
- Q3 2026: F&G returned $37 million of capital to shareholders from common and preferred dividends.
- Nine months 2026: capital returned to shareholders totaled $232 million, consisting of $112 million of dividends and $120 million of share repurchases.
- Book value per common share excluding AOCI bridge for the nine months ended September 30, 2026 shows capital actions of $0.10 per share.
- Common shares outstanding were 131 million at September 30, 2026 against 136 million at December 31, 2025 (reconciliation table).
- Treasury stock was $(163) million at September 30, 2026 against $(40) million at December 31, 2025.
What drove it
- Record AUM before reinsurance of $76.2 billion, up 7% year over year, which the company attributes to record core retail sales.
- Equity attributable to common shareholders excluding AOCI rose by $712 million, or $5.44 per share, from June 30, 2026, which the company states was primarily driven by $652 million of favorable market related liability adjustments, including $297 million of actuarial reserve release following the annual assumption review.
- Adjusted net earnings for Q3 2026 included investment income from alternative investments of $60 million, or $0.46 per share, which the company states was below management's current long-term expected return of approximately 12%.
- Adjusted net earnings for Q3 2025 included income from a $10 million, or $0.07 per share, tax valuation allowance benefit and $4 million, or $0.03 per share, of actuarial reserve release, and investment income from alternative investments of $53 million, or $0.38 per share, below the long-term expected return.
- Per the company, total product margin was reduced after reflecting the F&G Life Re (Bermuda) sale, lower surrender charge fee income, and higher other liability costs that include increased amortization expense, as expected.
- Per the company, these items were partially offset by steady fees from accretive flow reinsurance, owned distribution margin, and disciplined expense management which continued to drive scale benefit.
- Net earnings for Q3 2026 included $648 million of net favorable mark-to-market effects and $8 million of other unfavorable items, all of which the company excludes from adjusted net earnings.
- Benefits and other changes in policy reserves were $26 million in Q3 2026 against $1,181 million in Q3 2025, and recognized gains and (losses), net were $83 million against $211 million.
Concerns
- Adjusted net earnings fell to $96 million ($0.74 per share) from $165 million ($1.22 per share), and adjusted ROE excluding AOCI was 6.7% against 8.8% in the prior year quarter.
- Alternative investment income of $60 million was below the approximately 12% long-term expected return, a shortfall of $0.46 per share in Q3 2026 as stated by the company.
- Gross sales fell to $3.0 billion from $4.2 billion and net sales fell to $1.4 billion from $2.8 billion; the company states that multiyear guaranteed annuity sales were de-emphasized because returns were below its threshold.
- Opportunistic sales were $643 million against $1,994 million a year earlier, and the company notes that opportunistic volumes vary quarter to quarter.
- Life insurance premiums and other fees fell to $330 million from $711 million in Q3 2025, and interest and investment income fell to $698 million from $748 million.
- Accumulated other comprehensive income (loss) moved to $(2,605) million from $(1,488) million at December 31, 2025, and book value per common share including AOCI was $31.48 at September 30, 2026.
- Reinsurance recoverable and funds withheld for reinsurance liabilities both increased since December 31, 2025, to $21,938 million and $17,837 million respectively.
What to watch
- Alternative investment returns against the approximately 12% long-term expected return, given the Q3 2026 shortfall of $60 million and the nine-month shortfall of $153 million reported by the company.
- Whether opportunistic sales (funding agreements and multiyear guaranteed annuities) recover from $643 million in Q3 2026 against $1,994 million in Q3 2025.
- Whether PRT sales recover from $172 million in Q3 2026 against $538 million in Q3 2025.
- Trajectory of total product margin after the F&G Life Re (Bermuda) sale, as the company describes it.
- Progress of flow reinsurance sales, which the company reports at $1,595 million for Q3 2026 against $1,438 million in Q3 2025, and their contribution to fee income.
- Sustainability of the $297 million actuarial reserve release and the $652 million of market related liability adjustments that drove the equity increase.
- Capital return pace: $232 million returned in the first nine months of 2026, including $120 million of share repurchases.
Balance sheet and cash flow
- Total assets were $103,810 million at September 30, 2026 against $98,430 million at December 31, 2025.
- Total investments were $69,859 million at September 30, 2026 against $69,442 million at December 31, 2025.
- Cash and cash equivalents were $1,560 million at September 30, 2026 against $1,486 million at December 31, 2025.
- Reinsurance recoverable, net of allowance, was $21,938 million at September 30, 2026 against $17,545 million at December 31, 2025.
- Funds withheld for reinsurance liabilities were $17,837 million at September 30, 2026 against $14,191 million at December 31, 2025.
- Contractholder funds were $65,069 million at September 30, 2026 against $62,726 million at December 31, 2025.
- Notes payable were $2,240 million at September 30, 2026 against $2,237 million at December 31, 2025.
- Total liabilities were $99,352 million at September 30, 2026 against $93,513 million at December 31, 2025.
- Total F&G Annuities & Life, Inc. shareholders' equity was $4,374 million at September 30, 2026 against $4,804 million at December 31, 2025.
- Accumulated other comprehensive income (loss) was $(2,605) million at September 30, 2026 against $(1,488) million at December 31, 2025.
- Total equity was $4,458 million at September 30, 2026 against $4,917 million at December 31, 2025.
- Retained earnings were $3,368 million at September 30, 2026 against $2,568 million at December 31, 2025.
- The filing does not include a cash flow statement; operating cash flow and free cash flow are not reported.
Analysis
F&G reported GAAP net earnings attributable to common shareholders of $736 million, or $5.48 per diluted share, for Q3 2026, against $114 million, or $0.85 per diluted share, in Q3 2025. The company states that Q3 2026 net earnings included $648 million of net favorable mark-to-market effects, and it excludes these from adjusted net earnings. Adjusted net earnings were $96 million, or $0.74 per share, against $165 million, or $1.22 per share, a year earlier. The gap between the two measures is the central fact of the quarter: GAAP earnings and book value rose on market related liability adjustments, while the adjusted earnings measure that the company says reflects its underlying economics declined.
On the growth side, AUM before reinsurance reached a record $76,232 million, up 7% from $71,430 million, and the company attributes this to record core retail sales. Indexed annuity (FIA/RILA) sales were $2,143 million against $1,665 million, and total core sales were $2,357 million against $2,244 million. Opportunistic sales fell to $643 million from $1,994 million, and gross sales fell to $3,000 million from $4,238 million. The company says it de-emphasized multiyear guaranteed annuities because returns were below its threshold, and it describes opportunistic volumes as varying with economics and market opportunity. Net sales of $1,405 million compared with $2,800 million, and the company links flow reinsurance to third parties ($1,595 million in Q3 2026 against $1,438 million) to the net figure.
In the income statement, total revenues fell to $1,131 million from $1,694 million, with life insurance premiums and other fees down to $330 million from $711 million and recognized gains of $83 million against $211 million. Benefits and other changes in policy reserves dropped to $26 million from $1,181 million, and market risk benefit gains were $(167) million against losses of $43 million. The company's own explanation for the adjusted earnings decline is that total product margin was reduced after the F&G Life Re (Bermuda) sale, by lower surrender charge fee income and by higher other liability costs including increased amortization, partly offset by flow reinsurance fees, owned distribution margin and expense management. Alternative investment income of $60 million, or $0.46 per share, was below the approximately 12% long-term expected return, and the company states this was a factor in adjusted results.
The balance sheet grew over the year. Total assets were $103,810 million at September 30, 2026, against $98,430 million at December 31, 2025, with mortgage loans up to $10,246 million from $7,891 million and reinsurance recoverable up to $21,938 million from $17,545 million. Total F&G shareholders' equity was $4,374 million against $4,804 million at year-end, as AOCI moved to $(2,605) million from $(1,488) million. Equity attributable to common shareholders excluding AOCI rose by $712 million to $6,729 million, and book value per common share excluding AOCI reached $51.37. Notes payable were $2,240 million against $2,237 million. Capital return was $232 million for the first nine months, including $112 million of dividends and $120 million of repurchases. The filing contains no cash flow statement and no forward guidance, so the read on cash generation and the outlook is limited to these disclosures.
Management, verbatim
F&G continued to build momentum in the third quarter, with record core retail sales driving assets under management before reinsurance to a record $76.2 billion. Importantly, we are generating this growth while maintaining our disciplined approach to pricing and profitability, prioritizing business that meets our return targets and allocating capital to the most attractive opportunities.
Conor Murphy, Chief Executive Officer and President
We also continue to make meaningful progress toward a more fee-based, higher margin and less capital intensive business while growing our core spread-based franchise. Our strong inforce book provides a stable foundation of earnings and capital generation, while our strategic reinsurance relationships and owned distribution platform provide additional sources of fee-based earnings and financial flexibility.
Conor Murphy, Chief Executive Officer and President
Not in the filing
stated, not guessed- No prior-period outlook was provided, so vs_prior_guidance is empty.
- The filing contains no forward financial guidance for revenue, margin, operating expenses or tax rate.
- No segment revenue table is reported; sales categories are presented as sales, not segment revenue.
- No consolidated cash flow statement; operating cash flow and free cash flow are not reported.
- Debt-to-capitalization ratio, excluding AOCI, is defined but no value is printed.
- Prior-year and prior-quarter comparisons are not printed for several lines (for example gross sales, net sales, core sales and most income statement lines versus Q2 2026).
- Year-over-year percentage changes are not printed for most dollar lines; only the AUM before reinsurance increase of 7% is stated.
- Q2 2026 values are not printed for the income statement, sales or adjusted earnings lines.
- Adjusted return on average equity and adjusted return on assets are not printed with a change figure.
- Consensus estimates, analyst expectations and share price reaction are not included in the documents.
- Dividends per common share and the dividend rate are not printed separately from the $37 million and $112 million capital return totals.
Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.